| 摘要 |
The application is directed to haloalkyl- substituted compounds of formula (I) wherein R7 represents haloalkyl; and R1, R2, R3, R4, R 5, R6 and R8 are as defined in the claims. The compounds are inhibitors of cysteine proteases, in particular cathepsins B, K, L, F and S and are therefore useful in treating diseases mediated by these proteases. Pharmaceutical compositions containing these compounds and their use are also disclosed.
|
